CTRI/2017/10/010306招募中未知
To study the effect Of saroglitazar on insulin sensitivity in patients with type 2 diabetes mellitus
试验速览
- 阶段
- 未知
- 状态
- 招募中
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Patients with T2DM between 30 and 60 years of age
- •2.Treatment naïve or on monotherapy with metformin/voglibose
- •3.Duration of Diabetes < 5 yr
- •4.GAD antibody negative status
- •5.HbA1c 7.0-9.0%
- •6.Serum triglyceride > 150mg/dL
- •7.BMI â?? 23-30 Kg/m2
排除标准
- •1.Type 1 diabetes mellitus or secondary diabetes
- •2.Past history of DKA or having ketonemia or ketonuria
- •3.Uncontrolled hypertension
- •4.Thyroid disorder
- •5.Renal dysfunction defined by eGFR < 60 ml/min/m2
- •6.Hepatic dysfunction (AST/ALT > 2.5 ULN, T.Bilirubin > 2 X ULN), myopathies
- •7.Receiving statins, fibrates, hormone replacement therapies and steroids
- •8.Seropositivity for HIV, HBV and HCV
- •9.Recent cardio vascular event ( <6 months)
- •10.History of malignancy
- •11.Active infection
- •12.Alcohol ( >14 units/ week or 112 gm pure alcohol for men, > 7 units/week or 56 gm pure alcohol for women) (26) or drug abuse
研究者
相似试验
已完成
不适用
The role of saroglitazar in the treatment of prediabetes and elevated lipid levelsCTRI/2016/03/006778Deogiri Diabetes Centre40
已完成
不适用
Effects of SGLT2 inhibitor (Suglat) on insulin sensitivity in patients with type 2 diabetes mellitus by the glucose clamp technique and the meal tolerance test.Type 2 diabetes mellitusJPRN-UMIN000014521Division of Cardiovascular Medicine, Endocrinology and Metabolism, Department of Molecular Medicine and Therapeutics, Tottori University Faculty of Medicine20
已完成
不适用
Effect of Pioglitazone on Insulin Resistance and Atherosclerosis in Renal Allograft Recipients Without DiabetesKidney TransplantationInsulin ResistanceAtherosclerosisNCT00598013Yonsei University83
进行中（未招募）
不适用
Clinical study on the insulin sensitizing effect of multiple administration of Vition (Meditop) in healthy human volunteers (Pilot study)EUCTR2011-001859-36-HUMeditop Pharmaceuticals Co. Ltd.
已完成
不适用
iraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results Trial in JapaACS patient with type II diabetesJPRN-UMIN000006817Department of Cardiovascular Medicine, Saga University20